{"ticker": {"uuid": "e3481ccf-1e5d-4bc7-8200-32511ce3e868", "symbol": "BWAY", "name": "Brainsway Ltd", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "Brainsway (NASDAQ:BWAY) Upgraded to Strong-Buy at Zacks Research", "summary": "Zacks Research has upgraded Brainsway (NASDAQ:BWAY) from a \"hold\" to a \"strong-buy\" rating, reflecting a generally bullish outlook from analysts. The medical device company, specializing in non-invasive neuromodulation therapies, reported better-than-expected Q1 earnings with EPS", "url": "https://www.marketbeat.com/instant-alerts/brainsway-nasdaqbway-upgraded-to-strong-buy-at-zacks-research-2026-07-15/", "source_name": "MarketBeat", "published_at": "2026-07-15T10:40:35", "published_display": "15 Jul 2026 10:40", "sentiment": "positive", "sentiment_pct": 81, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Brainsway (NASDAQ:BWAY) Shares Down 6.8% - Here's Why", "summary": "Brainsway (NASDAQ:BWAY) shares dropped 6.8% on Monday, closing at $14.04 with significantly lower trading volume. Despite the dip, analyst sentiment remains generally positive, with a \"Moderate Buy\" consensus rating and an average target price of $16.00. The company recently exce", "url": "https://www.marketbeat.com/instant-alerts/brainsway-nasdaqbway-shares-down-68-heres-why-2026-07-13/", "source_name": "MarketBeat", "published_at": "2026-07-13T14:41:08", "published_display": "13 Jul 2026 14:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Y.D. More Investments Ltd Raises Stake in Brainsway Ltd. Sponsored ADR $BWAY", "summary": "Y.D. More Investments Ltd significantly increased its holdings in Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) by 136.6% in the first quarter, now owning 272,004 shares valued at $3.6 million. Other institutional investors also raised stakes, bringing total institutional ownership ", "url": "https://www.marketbeat.com/instant-alerts/filing-yd-more-investments-ltd-raises-stake-in-brainsway-ltd-sponsored-adr-bway-2026-07-13/", "source_name": "MarketBeat", "published_at": "2026-07-13T11:12:48", "published_display": "13 Jul 2026 11:12", "sentiment": "positive", "sentiment_pct": 70, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price-Driven Insight from (BWAY) for Rule-Based Strategy", "summary": "This article provides a price-driven insight for Brainsway Ltd. (NASDAQ: BWAY) focusing on rule-based trading strategies. It highlights a weak near-term sentiment but strong mid and long-term outlooks, with an exceptional risk-reward setup targeting a 32.3% gain. The piece outlin", "url": "https://news.stocktradersdaily.com/news_release/89/Price-Driven_Insight_from_BWAY_for_Rule-Based_Strategy_071126103402_1783823642.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-11T22:34:00", "published_display": "11 Jul 2026 22:34", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BWAY - Brainsway Ltd ADR Latest SEC Filings", "summary": "This page provides detailed financial data and performance metrics for Brainsway Ltd ADR (BWAY), including its latest stock price, changes, market capitalization, income, sales, and various financial ratios. It also presents information on EPS, sales growth, insider and instituti", "url": "https://finviz.com/stock?t=BWAY&ta=1&p=w&ty=lf&page=9", "source_name": "Finviz", "published_at": "2026-07-04T11:39:39", "published_display": "04 Jul 2026 11:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BWAY - Brainsway Ltd ADR Options", "summary": "This article provides a detailed financial overview of Brainsway Ltd ADR (BWAY), including its recent stock performance, key financial metrics, and valuation ratios. It lists various indicators such as market capitalization, income, sales, P/E ratio, EPS growth, insider and insti", "url": "https://finviz.com/stock?t=BWAY&ta=1&p=w&ty=oc&ov=list_strike&s=22.5", "source_name": "Finviz", "published_at": "2026-07-03T23:10:57", "published_display": "03 Jul 2026 23:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BWAY - Brainsway Ltd ADR Short Interest", "summary": "This article provides a detailed financial overview of Brainsway Ltd. (BWAY), an ADR in the medical devices sector. It includes various financial metrics such as market cap, income, sales, P/E ratios, employee count, and stock performance data. Key short interest figures like sho", "url": "https://finviz.com/stock?t=BWAY&ta=1&p=w&ty=si", "source_name": "Finviz", "published_at": "2026-07-03T12:10:23", "published_display": "03 Jul 2026 12:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brainsway stock rating reiterated at Buy by H.C. Wainwright on PTSD data", "summary": "H.C. Wainwright has reiterated a Buy rating and a $17.00 price target for Brainsway (NASDAQ:BWAY) following the presentation of real-world data on its Deep Transcranial Magnetic Stimulation (Deep TMS) treatment for patients suffering from both PTSD and major depressive disorder. ", "url": "https://za.investing.com/news/stock-market-news/brainsway-stock-rating-reiterated-at-buy-by-hc-wainwright-on-ptsd-data-93CH-4353780", "source_name": "Investing.com South Africa", "published_at": "2026-07-02T12:12:30", "published_display": "02 Jul 2026 12:12", "sentiment": "positive", "sentiment_pct": 75, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BrainsWay Unveils Strong Real-World Deep TMS Data in Comorbid PTSD and Depression", "summary": "BrainsWay has released real-world data showing strong efficacy of its Deep TMS in 462 patients with comorbid PTSD and major depressive disorder. The study indicated significant reductions in both PTSD and depression symptoms, suggesting potential benefits for complex psychiatric ", "url": "https://www.tipranks.com/news/company-announcements/brainsway-unveils-strong-real-world-deep-tms-data-in-comorbid-ptsd-and-depression", "source_name": "TipRanks", "published_at": "2026-06-29T23:09:40", "published_display": "29 Jun 2026 23:09", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BrainsWay Presents Positive Data from Largest Real-World Study of Deep TMS\u2122 in Patients with Comorbid PTSD and Major Depressive Disorder", "summary": "BrainsWay announced positive real-world data showing significant improvements in patients with comorbid PTSD and Major Depressive Disorder treated with Deep Transcranial Magnetic Stimulation (Deep TMS\u2122). The study, the largest of its kind, found 83.5% of patients responded with a", "url": "https://www.globenewswire.com/de/news-release/2026/06/29/3318863/0/en/brainsway-presents-positive-data-from-largest-real-world-study-of-deep-tms-in-patients-with-comorbid-ptsd-and-major-depressive-disorder.html", "source_name": "GlobeNewswire", "published_at": "2026-06-29T22:39:40", "published_display": "29 Jun 2026 22:39", "sentiment": "positive", "sentiment_pct": 80, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BrainsWay reports Deep TMS PTSD and depression data", "summary": "BrainsWay reported positive real-world data from a study of Deep Transcranial Magnetic Stimulation (Deep TMS) in 462 patients with comorbid PTSD and major depressive disorder. The study showed an 83.5% response rate for PTSD and a 66.6% response rate for depression, with a 27.3% ", "url": "https://grafa.com/en/news/united-states/brainsway-deep-tms-ptsd-depression-real-world-data", "source_name": "grafa.com", "published_at": "2026-06-29T12:50:00", "published_display": "29 Jun 2026 12:50", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Deep TMS shows strong PTSD and depression response in BrainsWay (NASDAQ: BWAY) study", "summary": "BrainsWay Ltd. (NASDAQ: BWAY) announced positive real-world data showing significant improvements in patients with comorbid Post-Traumatic Stress Disorder (PTSD) and Major Depressive Disorder (MDD) treated with Deep Transcranial Magnetic Stimulation (Deep TMS\u2122). A retrospective s", "url": "https://www.stocktitan.net/sec-filings/BWAY/6-k-brainsway-ltd-current-report-foreign-issuer-4eb34296d65b.html", "source_name": "Stock Titan", "published_at": "2026-06-29T11:11:32", "published_display": "29 Jun 2026 11:11", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BrainsWay Ltd (BWAY) Stock Forecast, Price Targets and Analysts Predictions", "summary": "This article from GuruFocus provides a stock forecast and price targets for BrainsWay Ltd (BWAY). It outlines key financial metrics such as market cap, enterprise value, P/E ratio, and P/B ratio, along with its GF Score. The article also mentions the availability of analyst ratin", "url": "https://www.gurufocus.com/stock/BWAY/forecast?r=caf6fe0e0db70d936033da5461e60141&utm_source=yahoo_finance&utm_medium=syndication&utm_campaign=headlines&utm_content=earnings_to_watch%3A_brainsway_ltd_%28bway%29_reports_q4_2025_result&utm_term=BWAY", "source_name": "GuruFocus", "published_at": "2026-06-28T21:11:32", "published_display": "28 Jun 2026 21:11", "sentiment": "positive", "sentiment_pct": 59, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Brainsway Ltd \u2013 TASE:BWAY", "summary": "This article provides financial context for Brainsway Ltd (TASE:BWAY), specifically focusing on its price-to-earnings forward metric. The content appears to be a stub or a section from a larger financial data platform, showing the company name, stock exchange, and a mention of ma", "url": "https://www.tradingview.com/symbols/TASE-BWAY/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T20:12:34", "published_display": "25 Jun 2026 20:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "H.C. Wainwright Maintains Brainsway(BWAY.US) With Buy Rating, Maintains Target Price $17", "summary": "H.C. Wainwright has reiterated its Buy rating for Brainsway (BWAY.US), maintaining a target price of $17. This indicates a continued positive outlook from the analyst firm on the company's stock performance and valuation.", "url": "https://www.moomoo.com/news/post/71895593/hc-wainwright-maintains-brainsway-bwayus-with-buy-rating-maintains-target", "source_name": "Moomoo", "published_at": "2026-06-23T12:40:28", "published_display": "23 Jun 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brainsway (BWAY) CTO sells 5,000 shares after exercising options", "summary": "Brainsway Ltd.'s Chief Technology Officer, Moiseyev Gilad, reported exercising stock options for 7,500 Ordinary Shares on May 25, 2026, and subsequently selling 5,000 Ordinary Shares in an open-market transaction on June 15, 2026, at NIS 42.0397 per share. The company retained 1,", "url": "https://www.stocktitan.net/sec-filings/BWAY/form-4-brainsway-ltd-insider-trading-activity-8e4f50ea3cb8.html", "source_name": "Stock Titan", "published_at": "2026-06-22T20:10:21", "published_display": "22 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BrainsWay expands U.S. insurance coverage for depression treatment", "summary": "BrainsWay Ltd. announced that eight major payers and the U.S. Department of Veterans Affairs now cover its SWIFT Accelerated Deep TMS protocol, impacting over 57 million lives. This expansion follows a South Carolina policy covering SWIFT, Deep TMS treatment for major depressive ", "url": "https://www.investing.com/news/company-news/brainsway-expands-us-insurance-coverage-for-depression-treatment-93CH-4752349", "source_name": "Investing.com", "published_at": "2026-06-22T18:40:50", "published_display": "22 Jun 2026 18:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BrainsWay Reports Favorable Coverage for Accelerated Deep TMS\u2122 Rises to Over 57 Million Covered Lives", "summary": "BrainsWay (NASDAQ & TASE: BWAY) announced a significant expansion in medical policy coverage for its SWIFT\u2122 Accelerated Deep TMS\u2122 protocol, now covering over 57 million lives in the U.S. This includes a new policy in South Carolina adding 2 million members and broader support fro", "url": "https://www.stocktitan.net/news/BWAY/brains-way-reports-favorable-coverage-for-accelerated-deep-tmstm-fbsxy4sp2764.html", "source_name": "Stock Titan", "published_at": "2026-06-22T11:09:29", "published_display": "22 Jun 2026 11:09", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "57M now covered for BrainsWay (NASDAQ: BWAY) accelerated Deep TMS", "summary": "BrainsWay Ltd. announced a significant expansion in insurance coverage for its SWIFT\u2122 Accelerated Deep TMS\u2122 protocol in the U.S., now covering over 57 million lives. This follows favorable policy changes, including a new policy in South Carolina covering 2 million members. Eight ", "url": "https://www.stocktitan.net/sec-filings/BWAY/6-k-brainsway-ltd-current-report-foreign-issuer-a36e17ffd03c.html", "source_name": "Stock Titan", "published_at": "2026-06-22T11:09:29", "published_display": "22 Jun 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BrainsWay wins South Carolina policy, lifting TMS coverage to 57M lives", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQYTRZWi1ScVRvMVVGa0lXcUJPVkp1aXhwSk1OY2M5OXFsbXVyN2VDY1VKNlBXV0RmVWQwQl8zMnpSUXEzSVNYUW5XM3JMMW9UZnJ4RC1jb1VJNWdjQV9aOXV4WkhfNXltZFZoaUtZNWJycEtIOGpvZ2w4RTFjT2czMm5vaFduMTYyMVVtaTJ5TzY3TDNsRDBUSy03QTJCcTJZMWxNSXo3Sm53eXVDMWFGbU9aYUtyaEVCZmhn?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(BWAY) as a Liquidity Pulse for Institutional Tactics", "summary": "This article analyzes Brainsway Ltd. (NASDAQ: BWAY) using AI models, highlighting a weak near and mid-term sentiment despite a long-term positive outlook. It provides specific institutional trading strategies, including position trading, momentum breakout, and risk hedging, along", "url": "https://news.stocktradersdaily.com/news_release/98/BWAY_as_a_Liquidity_Pulse_for_Institutional_Tactics_061926081402_1781914442.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-19T20:14:00", "published_display": "19 Jun 2026 20:14", "sentiment": "positive", "sentiment_pct": 67, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brainsway Ltd (BWAY) Financial Health: Profitability & Balance Sheet Analysis", "summary": "Brainsway Ltd (BWAY) has a strong financial health score of 8.94, ranking 16th in its industry, indicating robust financial status and high operating efficiency. The company reported a significant year-over-year revenue increase of 34.63% to $15.53 million, and its net profit sur", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bway/financial-health", "source_name": "TradingKey", "published_at": "2026-06-18T16:40:01", "published_display": "18 Jun 2026 16:40", "sentiment": "positive", "sentiment_pct": 73, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brainsway Ltd (BWAY) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for Brainsway Ltd (BWAY), detailing its current earnings forecast score, analyst ratings, and price targets. Brainsway Ltd has an earnings forecast score of 8.67, ranking 17th in its industry, with an average analyst price target of USD ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bway/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T16:40:01", "published_display": "18 Jun 2026 16:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Strength Seen in Brainsway (BWAY): Can Its 5.3% Jump Turn into More Strength?", "summary": "This article from MSN discusses the stock performance of Brainsway (BWAY), noting a recent 5.3% increase. The piece likely delves into whether this upward movement signifies a trend towards further strengthening of the stock. It anticipates analyzing potential factors contributin", "url": "http://www.msn.com/en-us/money/markets/strength-seen-in-brainsway-bway-can-its-53-jump-turn-into-more-strength/ar-AA1HkqhS?apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1", "source_name": "MSN", "published_at": "2026-06-17T13:09:38", "published_display": "17 Jun 2026 13:09", "sentiment": "positive", "sentiment_pct": 76, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brainsway Ltd (BWAY) Institutional Confidence", "summary": "The article analyzes the institutional confidence in Brainsway Ltd (BWAY), noting its current institutional shareholding score of 3.00, which ranks 132nd in the Healthcare Equipment & Supplies industry. It highlights that the institutional shareholding proportion is 30.66%, a 5.6", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bway/sentiment", "source_name": "TradingKey", "published_at": "2026-06-17T04:09:38", "published_display": "17 Jun 2026 04:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brainsway Ltd (BWAY) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Brainsway Ltd (BWAY), detailing its current price momentum, support and resistance levels, and indicator and moving average readings. Brainsway Ltd's current price momentum score is 7.10, ranking 70 out of 204 in its industry, with th", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bway/technical", "source_name": "TradingKey", "published_at": "2026-06-17T04:09:38", "published_display": "17 Jun 2026 04:09", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brainsway Ltd (BWAY) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a brief overview of Brainsway Ltd (BWAY) revenue breakdown. It shows that in terms of regional revenue, the United States accounts for 81.01% with $33.23M, while \"Other\" regions contribute 18.99% with $7.79M, totaling $41.02M. The company has not yet disclos", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bway/revenue", "source_name": "TradingKey", "published_at": "2026-06-17T02:40:01", "published_display": "17 Jun 2026 02:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brainsway Ltd (BWAY) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of Brainsway Ltd (BWAY)'s dividend and stock split history. It notes that the company has not distributed any dividends in the past five years but does list a stock split event that occurred on February 17, 2026. The page also includes current st", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bway/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-17T01:40:53", "published_display": "17 Jun 2026 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "BrainsWay Presents First SWIFT\u2122 Accelerated Deep TMS", "summary": "BrainsWay presented new 12-month durability data for its SWIFT\u2122 accelerated Deep TMS protocol for Major Depressive Disorder (MDD) at the Clinical TMS Society Annual Meeting. The data shows over 80% remission one year after treatment, with severe functional impairment dropping fro", "url": "https://www.globenewswire.com/news-release/2026/06/09/3308719/17676/en/brainsway-presents-first-swift-accelerated-deep-tms-12-month-durability-data-at-clinical-tms-society-annual-meeting.html", "source_name": "GlobeNewswire", "published_at": "2026-06-10T01:39:27", "published_display": "10 Jun 2026 01:39", "sentiment": "positive", "sentiment_pct": 81, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BrainsWay Presents First SWIFT\u2122 Accelerated Deep TMS 12-Month Durability Data at Clinical TMS Society Annual Meeting", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/brainsway-presents-first-swift-accelerated-113000454.html", "source_name": "GlobeNewswire", "published_at": "2026-06-09T11:30:00+00:00", "published_display": "09 Jun 2026 11:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Year-long depression relief: 80% stay in remission after BrainsWay's rapid TMS", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPRmw3VXg5T0lseVpLNTF0aXlZTk04YWVCQjd5Z2hpQkJBOHRVUk1WREJHemltSmZ3NVh0WVEwLTJTQWt4alN4NFAzMWRYdlozYXpESFRUZzFtQTAxUFRhMVFEUTR1dXFqNzlrRFhpMUluQ3IwZWFjM3NRc29KclhaTEZ1RjBCVjZZbXEwcGNFMHFQYi1iRnYxQWFVUnhkd2lJLW1ranpERHhpWnRmQ0FmTWhWbVNkcUFSSFE?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BrainsWay (BWAY) reports 12-month SWIFT Deep TMS depression durability data", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQdXM5Q0E3RDdCUUhrM21CVHV3UVd2UnN1b2lfSVBsc3dVd0xoN1dVWTBsVFhlWGhCS3NZQ3JDYkxsSU53cW9PbTg2dmI3Z3ZmeE1sSUQxX3lPRnNBcDZSdFRBa1NyMDRrNktOeDZxNlZSYkYwWGJkUVV2dHZMWHdqdkJCUXIxb3B3RlptazVxRjVFeU9WZF9ObDE1Y3NWRVphcDczbE9RVEJIVy1KRkE?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "BrainsWay Announces Minority-Stake Investment in Hopemark Health", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/brainsway-announces-minority-stake-investment-113000487.html", "source_name": "GlobeNewswire", "published_at": "2026-05-18T11:30:00+00:00", "published_display": "18 May 2026 11:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BrainsWay backs Chicago-area mental health clinics with $1.5M stake", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxORXBQWjQySk1MelJlVEJDVGF2N2pMLUp4Tmd2U2VXWGU5c1IzTVdVTWxsZ2VzMW1KYWhqczM1LWhQZHRPQmRfREluNnNGaTB1MEoxaVNlZE1NbnJlVFRsTzV2dkxyamlOZnZZcllQNVVxcXN3dnRPUVdNWUdJeVBTdU1ZUEtvb3lLZE5EVzE5alVmVmVPTFVJd0pDSF9qb0tZN24zZWY2MmUwQkd5V0NVVmRIWQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BrainsWay Ltd (BRSYF) Q1 2026 Earnings Call Highlights: Record Revenue Growth and Strategic ...", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/brainsway-ltd-brsyf-q1-2026-230202985.html", "source_name": "GuruFocus.com", "published_at": "2026-05-13T23:02:02+00:00", "published_display": "13 May 2026 23:02", "sentiment": "positive", "sentiment_pct": 83, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brainsway Q1 Earnings Call Highlights", "summary": "", "url": "https://finance.yahoo.com/m/7de74c33-e8bf-3439-b374-c19b8672a7f1/brainsway-q1-earnings-call.html", "source_name": "MarketBeat", "published_at": "2026-05-13T14:07:48+00:00", "published_display": "13 May 2026 14:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Are Medical Stocks Lagging Brainsway (BWAY) This Year?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQcEFpWDhfMEFQRC1kSXh2VnNGRU1jMDdFbnpUaWJ0aUwwZE1oTUVRVmNzcU5pUDBudW41WHpGeGttMFNBbEpRWWYzc0NEV0ZPakozdl9nM29WWDl5OHk3WVJ5a0p6VjhWdTloaVhBQzNabWZ2RnJwNWtjVW1xQnd0LWs1clNrYnVVVi0zZUVZal9vNmhFVjRVWWhYMzBfVDdqTk9Faw?oc=5", "source_name": "Market source", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BrainsWay opens May 13 with earnings release, 8:30 a.m. webcast", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPMXVBQmJDeGdKSzdlcXBJR0Y0cExRU0pHbjZxSVZOSXdybU1lMEIwMjl4QTFlMWcyUHFBNm10YUtjbHUyUUs0elg1eUQ0MEljc0FYeDBIMm9yTVBKa0xEeDdKZ0Z4YVo5OUhxTGpKU2kwRmkzMWRrd29Vdll4MVVmWUJOTDRSbGRSU0pISnk1dWNLTE1JSGFPN0tYTHpYVWRKMk5MY09uVnZ2UkFTcnFzaHJycURTLVZPVXViYnBvTQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "BrainsWay: Competitive Threats Are Mounting (NASDAQ:BWAY)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxNNHNCUnAtcXVwYUY0MnZTNG5oeG1Dak5XdTBXNWJ0WFhRNkpoOHh1Z2xkX25BMFc3TVBybVpEU2VuZWZld2VNRXJXb3FHeW1UUnlZeXUzdVpxZmVHcVNkTXlNa1VnMFdPYkE3YXNDQnptclFiTW11Z3puaWgxd2JBSl82aEFuWkpIOUlB?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-24T07:00:00+00:00", "published_display": "24 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brainsway (BWAY) Upgraded to Strong Buy: Here's What You Should Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNTUdMejRzSG8xSnBGY3A2X0ZKdWI0b3BSNV9LNHVZUUpqWjNaaHItUEFhOFhnTlJaeE9NSjBNMUE1eks2Q0VtLWhnM2dkOXdESjZKc0JZSjYwMXNQSmd4SE1FOTFIakE5eExDanRYTXo0ZTJBZm9NYXZSdkxrSmxKd3JPRFMzSXJNU0dMLWhvdExjSWQ0dldGYWtIcEpFb2JP?oc=5", "source_name": "Market source", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BrainsWay management takes virtual healthcare conference slot Wednesday", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNU0hyT2dzUEFSTmhLSVBpUlRTTUlSRzJUQ3FCQ2tUUDlJa2FMRDlrb3BBMm4wSzg4Y09HMnptZ19VdmNHQXlhdGRORm94WjdlUlZYOEl3VzdpREM2WmhNQlpwMnNNSy1id3JOeXhEMDVWYjJOQ3hLaDlyTVlfbWdqb3BQTEIxX21tS2N0Zmk5VDl1RGVqM1JRc3d0TU54SHFydF92Rm9oWEYtUU1wbGo0RTZ1YXpkdw?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brainsway (BWAY) Is a Great Choice for 'Trend' Investors, Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQOGpJWjNlclY0alZ2TXltbHlGc1ZnSEVEZkJzNG83ZkdzbUNra1F3OS1oZmd1VFFqbE1JczVMa1FOQlJqa3hlaEw3djRoZTJSeHctVm1xbHZ3eHRablBHVlpmOTRNbnlPMnJoTkZTZ0p3bmEzcGpfc2RWd3ZtMWFIRnROMi1kei1aQWxmcXBWMEZDY0tBa3JYX21qNXdLclU?oc=5", "source_name": "Market source", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Zacks.com featured highlights include Cardinal Infrastructure, BrainsWay and Century Aluminum", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPZHF6MnFNYUY2TFJsMW81WURRSThTeGxlMnMza2FKckU4YjRsY18zVkhrYXZteWNfYTFGQU1lT2xpWVYzaHYyNDlaMTRjSElCX0lFQnIwMWo2OEtNY1lUSTViazZGUXhaNzE1RFJpNUhRTHhaQnVfRE9RV2g3eHZMMDRteUNlTFlNMTZKblRPazhlRlFacER1c1ZVaElXRWZlSk1VQjhn?oc=5", "source_name": "Market source", "published_at": "2026-04-06T07:00:00+00:00", "published_display": "06 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Brainsway (BWAY) Might be Well Poised for a Surge", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxOVnlrWGF6MFNkSnVWNWtiR2FyM2NldS02aFR0TW1DTjlYYXZWekdjZUNDSElnU281V1ZrTmhsSjVHb0dHTFZqeFN4VnV1VC1jUU9OSE1tblVoZlBEbjFvNWxYeXZmX2VVNVZnUnQzV05RZndzelAtTjUzQ1lnclF4aGhmdXFGZEk0dzZWSFpKT2JpN3E2dE1jWW1R?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOb3BiQVNFREdNblk2QS10b1lhRUtfb05vU2VFZHB5V0hJT0R4NmhwQWRrcFVsR3UwMjZleFV6N2FEelpZVzY3YWFxSWE1cWpLaTFrQVU4NktkQUloUkxaV3ZTVkh6b1ZmaDdMN2ViX1BUNE4xUTNUZFNlR0syVGlZSg?oc=5", "source_name": "Market source", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "BrainsWay Announces Change in ADS-to-Ordinary Share Ratio", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxPQnRUYmlKa0ZPbWhLNUk2d1dUUkZ1OU1MMDBYSC10UExVN0F4Q1NKeDNhZkF4aVJ2Q1h1Q3dkbkg1UEhra0M5RV9pYzYyYUpWd0xmcHJOYjZtaGg2WFZsV0pjVHpHem5paUVjeUdLN2p1S3RrUUxpWTh0R24yTWs4RHJJOFpIaVIyRENwVWNR?oc=5", "source_name": "Market source", "published_at": "2026-02-17T08:00:00+00:00", "published_display": "17 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brainsway (BWAY) Stock News & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTE9mZUhLWjZNa2xkZ0dFZGUyMlhwRENVRklOTEhFeVkyWGdVTGVwaWV3UWxQTElwVzlZRXZxa3BFbmgtS21PUDc5UjVUbHJkUQ?oc=5", "source_name": "Stock Titan", "published_at": "2020-09-04T17:15:34+00:00", "published_display": "04 Sep 2020 17:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brainsway (BWAY) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTFByQkk3akwxUXlGbk1YeWU3TnRHclhEUEpGUjhrUnRNZzdaa1NRaXZTTzJOTEpsaE9Db1gzM1lKS1RaajRMNEhYdjFlaHNNY3ZRQ2pBamhDSDgyZw?oc=5", "source_name": "MarketBeat", "published_at": "2019-05-01T12:38:20+00:00", "published_display": "01 May 2019 12:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Brainsway (NASDAQ:BWAY) Upgraded to Strong-Buy at Zacks Research", "summary": "Zacks Research has upgraded Brainsway (NASDAQ:BWAY) from a \"hold\" to a \"strong-buy\" rating, reflecting a generally bullish outlook from analysts. The medical device company, specializing in non-invasive neuromodulation therapies, reported better-than-expected Q1 earnings with EPS", "url": "https://www.marketbeat.com/instant-alerts/brainsway-nasdaqbway-upgraded-to-strong-buy-at-zacks-research-2026-07-15/", "source_name": "MarketBeat", "published_at": "2026-07-15T10:40:35", "published_display": "15 Jul 2026 10:40", "sentiment": "positive", "sentiment_pct": 81, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brainsway (NASDAQ:BWAY) Shares Down 6.8% - Here's Why", "summary": "Brainsway (NASDAQ:BWAY) shares dropped 6.8% on Monday, closing at $14.04 with significantly lower trading volume. Despite the dip, analyst sentiment remains generally positive, with a \"Moderate Buy\" consensus rating and an average target price of $16.00. The company recently exce", "url": "https://www.marketbeat.com/instant-alerts/brainsway-nasdaqbway-shares-down-68-heres-why-2026-07-13/", "source_name": "MarketBeat", "published_at": "2026-07-13T14:41:08", "published_display": "13 Jul 2026 14:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Y.D. More Investments Ltd Raises Stake in Brainsway Ltd. Sponsored ADR $BWAY", "summary": "Y.D. More Investments Ltd significantly increased its holdings in Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) by 136.6% in the first quarter, now owning 272,004 shares valued at $3.6 million. Other institutional investors also raised stakes, bringing total institutional ownership ", "url": "https://www.marketbeat.com/instant-alerts/filing-yd-more-investments-ltd-raises-stake-in-brainsway-ltd-sponsored-adr-bway-2026-07-13/", "source_name": "MarketBeat", "published_at": "2026-07-13T11:12:48", "published_display": "13 Jul 2026 11:12", "sentiment": "positive", "sentiment_pct": 70, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price-Driven Insight from (BWAY) for Rule-Based Strategy", "summary": "This article provides a price-driven insight for Brainsway Ltd. (NASDAQ: BWAY) focusing on rule-based trading strategies. It highlights a weak near-term sentiment but strong mid and long-term outlooks, with an exceptional risk-reward setup targeting a 32.3% gain. The piece outlin", "url": "https://news.stocktradersdaily.com/news_release/89/Price-Driven_Insight_from_BWAY_for_Rule-Based_Strategy_071126103402_1783823642.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-11T22:34:00", "published_display": "11 Jul 2026 22:34", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BWAY - Brainsway Ltd ADR Latest SEC Filings", "summary": "This page provides detailed financial data and performance metrics for Brainsway Ltd ADR (BWAY), including its latest stock price, changes, market capitalization, income, sales, and various financial ratios. It also presents information on EPS, sales growth, insider and instituti", "url": "https://finviz.com/stock?t=BWAY&ta=1&p=w&ty=lf&page=9", "source_name": "Finviz", "published_at": "2026-07-04T11:39:39", "published_display": "04 Jul 2026 11:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BWAY - Brainsway Ltd ADR Options", "summary": "This article provides a detailed financial overview of Brainsway Ltd ADR (BWAY), including its recent stock performance, key financial metrics, and valuation ratios. It lists various indicators such as market capitalization, income, sales, P/E ratio, EPS growth, insider and insti", "url": "https://finviz.com/stock?t=BWAY&ta=1&p=w&ty=oc&ov=list_strike&s=22.5", "source_name": "Finviz", "published_at": "2026-07-03T23:10:57", "published_display": "03 Jul 2026 23:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BWAY - Brainsway Ltd ADR Short Interest", "summary": "This article provides a detailed financial overview of Brainsway Ltd. (BWAY), an ADR in the medical devices sector. It includes various financial metrics such as market cap, income, sales, P/E ratios, employee count, and stock performance data. Key short interest figures like sho", "url": "https://finviz.com/stock?t=BWAY&ta=1&p=w&ty=si", "source_name": "Finviz", "published_at": "2026-07-03T12:10:23", "published_display": "03 Jul 2026 12:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brainsway stock rating reiterated at Buy by H.C. Wainwright on PTSD data", "summary": "H.C. Wainwright has reiterated a Buy rating and a $17.00 price target for Brainsway (NASDAQ:BWAY) following the presentation of real-world data on its Deep Transcranial Magnetic Stimulation (Deep TMS) treatment for patients suffering from both PTSD and major depressive disorder. ", "url": "https://za.investing.com/news/stock-market-news/brainsway-stock-rating-reiterated-at-buy-by-hc-wainwright-on-ptsd-data-93CH-4353780", "source_name": "Investing.com South Africa", "published_at": "2026-07-02T12:12:30", "published_display": "02 Jul 2026 12:12", "sentiment": "positive", "sentiment_pct": 75, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BrainsWay Unveils Strong Real-World Deep TMS Data in Comorbid PTSD and Depression", "summary": "BrainsWay has released real-world data showing strong efficacy of its Deep TMS in 462 patients with comorbid PTSD and major depressive disorder. The study indicated significant reductions in both PTSD and depression symptoms, suggesting potential benefits for complex psychiatric ", "url": "https://www.tipranks.com/news/company-announcements/brainsway-unveils-strong-real-world-deep-tms-data-in-comorbid-ptsd-and-depression", "source_name": "TipRanks", "published_at": "2026-06-29T23:09:40", "published_display": "29 Jun 2026 23:09", "sentiment": "positive", "sentiment_pct": 73, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BrainsWay Presents Positive Data from Largest Real-World Study of Deep TMS\u2122 in Patients with Comorbid PTSD and Major Depressive Disorder", "summary": "BrainsWay announced positive real-world data showing significant improvements in patients with comorbid PTSD and Major Depressive Disorder treated with Deep Transcranial Magnetic Stimulation (Deep TMS\u2122). The study, the largest of its kind, found 83.5% of patients responded with a", "url": "https://www.globenewswire.com/de/news-release/2026/06/29/3318863/0/en/brainsway-presents-positive-data-from-largest-real-world-study-of-deep-tms-in-patients-with-comorbid-ptsd-and-major-depressive-disorder.html", "source_name": "GlobeNewswire", "published_at": "2026-06-29T22:39:40", "published_display": "29 Jun 2026 22:39", "sentiment": "positive", "sentiment_pct": 80, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BrainsWay reports Deep TMS PTSD and depression data", "summary": "BrainsWay reported positive real-world data from a study of Deep Transcranial Magnetic Stimulation (Deep TMS) in 462 patients with comorbid PTSD and major depressive disorder. The study showed an 83.5% response rate for PTSD and a 66.6% response rate for depression, with a 27.3% ", "url": "https://grafa.com/en/news/united-states/brainsway-deep-tms-ptsd-depression-real-world-data", "source_name": "grafa.com", "published_at": "2026-06-29T12:50:00", "published_display": "29 Jun 2026 12:50", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Deep TMS shows strong PTSD and depression response in BrainsWay (NASDAQ: BWAY) study", "summary": "BrainsWay Ltd. (NASDAQ: BWAY) announced positive real-world data showing significant improvements in patients with comorbid Post-Traumatic Stress Disorder (PTSD) and Major Depressive Disorder (MDD) treated with Deep Transcranial Magnetic Stimulation (Deep TMS\u2122). A retrospective s", "url": "https://www.stocktitan.net/sec-filings/BWAY/6-k-brainsway-ltd-current-report-foreign-issuer-4eb34296d65b.html", "source_name": "Stock Titan", "published_at": "2026-06-29T11:11:32", "published_display": "29 Jun 2026 11:11", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BrainsWay Ltd (BWAY) Stock Forecast, Price Targets and Analysts Predictions", "summary": "This article from GuruFocus provides a stock forecast and price targets for BrainsWay Ltd (BWAY). It outlines key financial metrics such as market cap, enterprise value, P/E ratio, and P/B ratio, along with its GF Score. The article also mentions the availability of analyst ratin", "url": "https://www.gurufocus.com/stock/BWAY/forecast?r=caf6fe0e0db70d936033da5461e60141&utm_source=yahoo_finance&utm_medium=syndication&utm_campaign=headlines&utm_content=earnings_to_watch%3A_brainsway_ltd_%28bway%29_reports_q4_2025_result&utm_term=BWAY", "source_name": "GuruFocus", "published_at": "2026-06-28T21:11:32", "published_display": "28 Jun 2026 21:11", "sentiment": "positive", "sentiment_pct": 59, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Brainsway Ltd \u2013 TASE:BWAY", "summary": "This article provides financial context for Brainsway Ltd (TASE:BWAY), specifically focusing on its price-to-earnings forward metric. The content appears to be a stub or a section from a larger financial data platform, showing the company name, stock exchange, and a mention of ma", "url": "https://www.tradingview.com/symbols/TASE-BWAY/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T20:12:34", "published_display": "25 Jun 2026 20:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "H.C. Wainwright Maintains Brainsway(BWAY.US) With Buy Rating, Maintains Target Price $17", "summary": "H.C. Wainwright has reiterated its Buy rating for Brainsway (BWAY.US), maintaining a target price of $17. This indicates a continued positive outlook from the analyst firm on the company's stock performance and valuation.", "url": "https://www.moomoo.com/news/post/71895593/hc-wainwright-maintains-brainsway-bwayus-with-buy-rating-maintains-target", "source_name": "Moomoo", "published_at": "2026-06-23T12:40:28", "published_display": "23 Jun 2026 12:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brainsway (BWAY) CTO sells 5,000 shares after exercising options", "summary": "Brainsway Ltd.'s Chief Technology Officer, Moiseyev Gilad, reported exercising stock options for 7,500 Ordinary Shares on May 25, 2026, and subsequently selling 5,000 Ordinary Shares in an open-market transaction on June 15, 2026, at NIS 42.0397 per share. The company retained 1,", "url": "https://www.stocktitan.net/sec-filings/BWAY/form-4-brainsway-ltd-insider-trading-activity-8e4f50ea3cb8.html", "source_name": "Stock Titan", "published_at": "2026-06-22T20:10:21", "published_display": "22 Jun 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BrainsWay expands U.S. insurance coverage for depression treatment", "summary": "BrainsWay Ltd. announced that eight major payers and the U.S. Department of Veterans Affairs now cover its SWIFT Accelerated Deep TMS protocol, impacting over 57 million lives. This expansion follows a South Carolina policy covering SWIFT, Deep TMS treatment for major depressive ", "url": "https://www.investing.com/news/company-news/brainsway-expands-us-insurance-coverage-for-depression-treatment-93CH-4752349", "source_name": "Investing.com", "published_at": "2026-06-22T18:40:50", "published_display": "22 Jun 2026 18:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BrainsWay Reports Favorable Coverage for Accelerated Deep TMS\u2122 Rises to Over 57 Million Covered Lives", "summary": "BrainsWay (NASDAQ & TASE: BWAY) announced a significant expansion in medical policy coverage for its SWIFT\u2122 Accelerated Deep TMS\u2122 protocol, now covering over 57 million lives in the U.S. This includes a new policy in South Carolina adding 2 million members and broader support fro", "url": "https://www.stocktitan.net/news/BWAY/brains-way-reports-favorable-coverage-for-accelerated-deep-tmstm-fbsxy4sp2764.html", "source_name": "Stock Titan", "published_at": "2026-06-22T11:09:29", "published_display": "22 Jun 2026 11:09", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "57M now covered for BrainsWay (NASDAQ: BWAY) accelerated Deep TMS", "summary": "BrainsWay Ltd. announced a significant expansion in insurance coverage for its SWIFT\u2122 Accelerated Deep TMS\u2122 protocol in the U.S., now covering over 57 million lives. This follows favorable policy changes, including a new policy in South Carolina covering 2 million members. Eight ", "url": "https://www.stocktitan.net/sec-filings/BWAY/6-k-brainsway-ltd-current-report-foreign-issuer-a36e17ffd03c.html", "source_name": "Stock Titan", "published_at": "2026-06-22T11:09:29", "published_display": "22 Jun 2026 11:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BrainsWay wins South Carolina policy, lifting TMS coverage to 57M lives", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQYTRZWi1ScVRvMVVGa0lXcUJPVkp1aXhwSk1OY2M5OXFsbXVyN2VDY1VKNlBXV0RmVWQwQl8zMnpSUXEzSVNYUW5XM3JMMW9UZnJ4RC1jb1VJNWdjQV9aOXV4WkhfNXltZFZoaUtZNWJycEtIOGpvZ2w4RTFjT2czMm5vaFduMTYyMVVtaTJ5TzY3TDNsRDBUSy03QTJCcTJZMWxNSXo3Sm53eXVDMWFGbU9aYUtyaEVCZmhn?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-22T07:00:00+00:00", "published_display": "22 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(BWAY) as a Liquidity Pulse for Institutional Tactics", "summary": "This article analyzes Brainsway Ltd. (NASDAQ: BWAY) using AI models, highlighting a weak near and mid-term sentiment despite a long-term positive outlook. It provides specific institutional trading strategies, including position trading, momentum breakout, and risk hedging, along", "url": "https://news.stocktradersdaily.com/news_release/98/BWAY_as_a_Liquidity_Pulse_for_Institutional_Tactics_061926081402_1781914442.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-19T20:14:00", "published_display": "19 Jun 2026 20:14", "sentiment": "positive", "sentiment_pct": 67, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brainsway Ltd (BWAY) Financial Health: Profitability & Balance Sheet Analysis", "summary": "Brainsway Ltd (BWAY) has a strong financial health score of 8.94, ranking 16th in its industry, indicating robust financial status and high operating efficiency. The company reported a significant year-over-year revenue increase of 34.63% to $15.53 million, and its net profit sur", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bway/financial-health", "source_name": "TradingKey", "published_at": "2026-06-18T16:40:01", "published_display": "18 Jun 2026 16:40", "sentiment": "positive", "sentiment_pct": 73, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brainsway Ltd (BWAY) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for Brainsway Ltd (BWAY), detailing its current earnings forecast score, analyst ratings, and price targets. Brainsway Ltd has an earnings forecast score of 8.67, ranking 17th in its industry, with an average analyst price target of USD ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bway/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T16:40:01", "published_display": "18 Jun 2026 16:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Strength Seen in Brainsway (BWAY): Can Its 5.3% Jump Turn into More Strength?", "summary": "This article from MSN discusses the stock performance of Brainsway (BWAY), noting a recent 5.3% increase. The piece likely delves into whether this upward movement signifies a trend towards further strengthening of the stock. It anticipates analyzing potential factors contributin", "url": "http://www.msn.com/en-us/money/markets/strength-seen-in-brainsway-bway-can-its-53-jump-turn-into-more-strength/ar-AA1HkqhS?apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1", "source_name": "MSN", "published_at": "2026-06-17T13:09:38", "published_display": "17 Jun 2026 13:09", "sentiment": "positive", "sentiment_pct": 76, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brainsway Ltd (BWAY) Institutional Confidence", "summary": "The article analyzes the institutional confidence in Brainsway Ltd (BWAY), noting its current institutional shareholding score of 3.00, which ranks 132nd in the Healthcare Equipment & Supplies industry. It highlights that the institutional shareholding proportion is 30.66%, a 5.6", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bway/sentiment", "source_name": "TradingKey", "published_at": "2026-06-17T04:09:38", "published_display": "17 Jun 2026 04:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brainsway Ltd (BWAY) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Brainsway Ltd (BWAY), detailing its current price momentum, support and resistance levels, and indicator and moving average readings. Brainsway Ltd's current price momentum score is 7.10, ranking 70 out of 204 in its industry, with th", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bway/technical", "source_name": "TradingKey", "published_at": "2026-06-17T04:09:38", "published_display": "17 Jun 2026 04:09", "sentiment": "negative", "sentiment_pct": 38, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brainsway Ltd (BWAY) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a brief overview of Brainsway Ltd (BWAY) revenue breakdown. It shows that in terms of regional revenue, the United States accounts for 81.01% with $33.23M, while \"Other\" regions contribute 18.99% with $7.79M, totaling $41.02M. The company has not yet disclos", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bway/revenue", "source_name": "TradingKey", "published_at": "2026-06-17T02:40:01", "published_display": "17 Jun 2026 02:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brainsway Ltd (BWAY) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of Brainsway Ltd (BWAY)'s dividend and stock split history. It notes that the company has not distributed any dividends in the past five years but does list a stock split event that occurred on February 17, 2026. The page also includes current st", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-bway/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-17T01:40:53", "published_display": "17 Jun 2026 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BrainsWay Presents First SWIFT\u2122 Accelerated Deep TMS", "summary": "BrainsWay presented new 12-month durability data for its SWIFT\u2122 accelerated Deep TMS protocol for Major Depressive Disorder (MDD) at the Clinical TMS Society Annual Meeting. The data shows over 80% remission one year after treatment, with severe functional impairment dropping fro", "url": "https://www.globenewswire.com/news-release/2026/06/09/3308719/17676/en/brainsway-presents-first-swift-accelerated-deep-tms-12-month-durability-data-at-clinical-tms-society-annual-meeting.html", "source_name": "GlobeNewswire", "published_at": "2026-06-10T01:39:27", "published_display": "10 Jun 2026 01:39", "sentiment": "positive", "sentiment_pct": 81, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BrainsWay Presents First SWIFT\u2122 Accelerated Deep TMS 12-Month Durability Data at Clinical TMS Society Annual Meeting", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/brainsway-presents-first-swift-accelerated-113000454.html", "source_name": "GlobeNewswire", "published_at": "2026-06-09T11:30:00+00:00", "published_display": "09 Jun 2026 11:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Year-long depression relief: 80% stay in remission after BrainsWay's rapid TMS", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxPRmw3VXg5T0lseVpLNTF0aXlZTk04YWVCQjd5Z2hpQkJBOHRVUk1WREJHemltSmZ3NVh0WVEwLTJTQWt4alN4NFAzMWRYdlozYXpESFRUZzFtQTAxUFRhMVFEUTR1dXFqNzlrRFhpMUluQ3IwZWFjM3NRc29KclhaTEZ1RjBCVjZZbXEwcGNFMHFQYi1iRnYxQWFVUnhkd2lJLW1ranpERHhpWnRmQ0FmTWhWbVNkcUFSSFE?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BrainsWay (BWAY) reports 12-month SWIFT Deep TMS depression durability data", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQdXM5Q0E3RDdCUUhrM21CVHV3UVd2UnN1b2lfSVBsc3dVd0xoN1dVWTBsVFhlWGhCS3NZQ3JDYkxsSU53cW9PbTg2dmI3Z3ZmeE1sSUQxX3lPRnNBcDZSdFRBa1NyMDRrNktOeDZxNlZSYkYwWGJkUVV2dHZMWHdqdkJCUXIxb3B3RlptazVxRjVFeU9WZF9ObDE1Y3NWRVphcDczbE9RVEJIVy1KRkE?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BrainsWay Announces Minority-Stake Investment in Hopemark Health", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/brainsway-announces-minority-stake-investment-113000487.html", "source_name": "GlobeNewswire", "published_at": "2026-05-18T11:30:00+00:00", "published_display": "18 May 2026 11:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BrainsWay backs Chicago-area mental health clinics with $1.5M stake", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxORXBQWjQySk1MelJlVEJDVGF2N2pMLUp4Tmd2U2VXWGU5c1IzTVdVTWxsZ2VzMW1KYWhqczM1LWhQZHRPQmRfREluNnNGaTB1MEoxaVNlZE1NbnJlVFRsTzV2dkxyamlOZnZZcllQNVVxcXN3dnRPUVdNWUdJeVBTdU1ZUEtvb3lLZE5EVzE5alVmVmVPTFVJd0pDSF9qb0tZN24zZWY2MmUwQkd5V0NVVmRIWQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BrainsWay Ltd (BRSYF) Q1 2026 Earnings Call Highlights: Record Revenue Growth and Strategic ...", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/brainsway-ltd-brsyf-q1-2026-230202985.html", "source_name": "GuruFocus.com", "published_at": "2026-05-13T23:02:02+00:00", "published_display": "13 May 2026 23:02", "sentiment": "positive", "sentiment_pct": 83, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brainsway Q1 Earnings Call Highlights", "summary": "", "url": "https://finance.yahoo.com/m/7de74c33-e8bf-3439-b374-c19b8672a7f1/brainsway-q1-earnings-call.html", "source_name": "MarketBeat", "published_at": "2026-05-13T14:07:48+00:00", "published_display": "13 May 2026 14:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Are Medical Stocks Lagging Brainsway (BWAY) This Year?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQcEFpWDhfMEFQRC1kSXh2VnNGRU1jMDdFbnpUaWJ0aUwwZE1oTUVRVmNzcU5pUDBudW41WHpGeGttMFNBbEpRWWYzc0NEV0ZPakozdl9nM29WWDl5OHk3WVJ5a0p6VjhWdTloaVhBQzNabWZ2RnJwNWtjVW1xQnd0LWs1clNrYnVVVi0zZUVZal9vNmhFVjRVWWhYMzBfVDdqTk9Faw?oc=5", "source_name": "Market source", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BrainsWay opens May 13 with earnings release, 8:30 a.m. webcast", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPMXVBQmJDeGdKSzdlcXBJR0Y0cExRU0pHbjZxSVZOSXdybU1lMEIwMjl4QTFlMWcyUHFBNm10YUtjbHUyUUs0elg1eUQ0MEljc0FYeDBIMm9yTVBKa0xEeDdKZ0Z4YVo5OUhxTGpKU2kwRmkzMWRrd29Vdll4MVVmWUJOTDRSbGRSU0pISnk1dWNLTE1JSGFPN0tYTHpYVWRKMk5MY09uVnZ2UkFTcnFzaHJycURTLVZPVXViYnBvTQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-29T07:00:00+00:00", "published_display": "29 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BrainsWay: Competitive Threats Are Mounting (NASDAQ:BWAY)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiwFBVV95cUxNNHNCUnAtcXVwYUY0MnZTNG5oeG1Dak5XdTBXNWJ0WFhRNkpoOHh1Z2xkX25BMFc3TVBybVpEU2VuZWZld2VNRXJXb3FHeW1UUnlZeXUzdVpxZmVHcVNkTXlNa1VnMFdPYkE3YXNDQnptclFiTW11Z3puaWgxd2JBSl82aEFuWkpIOUlB?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-24T07:00:00+00:00", "published_display": "24 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brainsway (BWAY) Upgraded to Strong Buy: Here's What You Should Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNTUdMejRzSG8xSnBGY3A2X0ZKdWI0b3BSNV9LNHVZUUpqWjNaaHItUEFhOFhnTlJaeE9NSjBNMUE1eks2Q0VtLWhnM2dkOXdESjZKc0JZSjYwMXNQSmd4SE1FOTFIakE5eExDanRYTXo0ZTJBZm9NYXZSdkxrSmxKd3JPRFMzSXJNU0dMLWhvdExjSWQ0dldGYWtIcEpFb2JP?oc=5", "source_name": "Market source", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BrainsWay management takes virtual healthcare conference slot Wednesday", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNU0hyT2dzUEFSTmhLSVBpUlRTTUlSRzJUQ3FCQ2tUUDlJa2FMRDlrb3BBMm4wSzg4Y09HMnptZ19VdmNHQXlhdGRORm94WjdlUlZYOEl3VzdpREM2WmhNQlpwMnNNSy1id3JOeXhEMDVWYjJOQ3hLaDlyTVlfbWdqb3BQTEIxX21tS2N0Zmk5VDl1RGVqM1JRc3d0TU54SHFydF92Rm9oWEYtUU1wbGo0RTZ1YXpkdw?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brainsway (BWAY) Is a Great Choice for 'Trend' Investors, Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxQOGpJWjNlclY0alZ2TXltbHlGc1ZnSEVEZkJzNG83ZkdzbUNra1F3OS1oZmd1VFFqbE1JczVMa1FOQlJqa3hlaEw3djRoZTJSeHctVm1xbHZ3eHRablBHVlpmOTRNbnlPMnJoTkZTZ0p3bmEzcGpfc2RWd3ZtMWFIRnROMi1kei1aQWxmcXBWMEZDY0tBa3JYX21qNXdLclU?oc=5", "source_name": "Market source", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Zacks.com featured highlights include Cardinal Infrastructure, BrainsWay and Century Aluminum", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxPZHF6MnFNYUY2TFJsMW81WURRSThTeGxlMnMza2FKckU4YjRsY18zVkhrYXZteWNfYTFGQU1lT2xpWVYzaHYyNDlaMTRjSElCX0lFQnIwMWo2OEtNY1lUSTViazZGUXhaNzE1RFJpNUhRTHhaQnVfRE9RV2g3eHZMMDRteUNlTFlNMTZKblRPazhlRlFacER1c1ZVaElXRWZlSk1VQjhn?oc=5", "source_name": "Market source", "published_at": "2026-04-06T07:00:00+00:00", "published_display": "06 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Brainsway (BWAY) Might be Well Poised for a Surge", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxOVnlrWGF6MFNkSnVWNWtiR2FyM2NldS02aFR0TW1DTjlYYXZWekdjZUNDSElnU281V1ZrTmhsSjVHb0dHTFZqeFN4VnV1VC1jUU9OSE1tblVoZlBEbjFvNWxYeXZmX2VVNVZnUnQzV05RZndzelAtTjUzQ1lnclF4aGhmdXFGZEk0dzZWSFpKT2JpN3E2dE1jWW1R?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BrainsWay Announces Change in ADS-to-Ordinary Share Ratio", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxPQnRUYmlKa0ZPbWhLNUk2d1dUUkZ1OU1MMDBYSC10UExVN0F4Q1NKeDNhZkF4aVJ2Q1h1Q3dkbkg1UEhra0M5RV9pYzYyYUpWd0xmcHJOYjZtaGg2WFZsV0pjVHpHem5paUVjeUdLN2p1S3RrUUxpWTh0R24yTWs4RHJJOFpIaVIyRENwVWNR?oc=5", "source_name": "Market source", "published_at": "2026-02-17T08:00:00+00:00", "published_display": "17 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brainsway (BWAY) Stock News & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTE9mZUhLWjZNa2xkZ0dFZGUyMlhwRENVRklOTEhFeVkyWGdVTGVwaWV3UWxQTElwVzlZRXZxa3BFbmgtS21PUDc5UjVUbHJkUQ?oc=5", "source_name": "Stock Titan", "published_at": "2020-09-04T17:15:34+00:00", "published_display": "04 Sep 2020 17:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Brainsway (BWAY) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTFByQkk3akwxUXlGbk1YeWU3TnRHclhEUEpGUjhrUnRNZzdaa1NRaXZTTzJOTEpsaE9Db1gzM1lKS1RaajRMNEhYdjFlaHNNY3ZRQ2pBamhDSDgyZw?oc=5", "source_name": "MarketBeat", "published_at": "2019-05-01T12:38:20+00:00", "published_display": "01 May 2019 12:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-22T07:00:00+00:00", "published_display": "22 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOb3BiQVNFREdNblk2QS10b1lhRUtfb05vU2VFZHB5V0hJT0R4NmhwQWRrcFVsR3UwMjZleFV6N2FEelpZVzY3YWFxSWE1cWpLaTFrQVU4NktkQUloUkxaV3ZTVkh6b1ZmaDdMN2ViX1BUNE4xUTNUZFNlR0syVGlZSg?oc=5", "source_name": "Market source", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 94, "total_relevant": 59, "sentiment_summary": {"positive": 19, "negative": 1, "neutral": 39, "score": 59, "total": 59, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 78, "events": [{"event": "general", "label": "Market update", "weight": 16.3, "count": 29}, {"event": "earnings", "label": "Earnings", "weight": 11.0, "count": 23}, {"event": "analyst", "label": "Analyst action", "weight": 1.65, "count": 3}, {"event": "guidance", "label": "Guidance", "weight": 1.1, "count": 2}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 19, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 15.06, "latest_week": "2026-07-10", "one_week_move": -0.9, "four_week_move": 2.9, "twelve_week_move": -4.7, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": -0.963009, "market_dynamics_buy_signal": false, "relative_strength": 20.547015, "fair_value_gap": 148.0, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 51.5873, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-0.9% over one week, +2.9% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 58, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 16}, {"label": "Stock Titan", "count": 11}, {"label": "TradingKey", "count": 6}, {"label": "MarketBeat", "count": 5}, {"label": "GlobeNewswire", "count": 4}, {"label": "Finviz", "count": 3}, {"label": "Stock Traders Daily", "count": 2}, {"label": "StockStory", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 47}, {"label": "Industry context", "count": 12}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 29}, {"label": "Earnings", "count": 23}, {"label": "Analyst action", "count": 3}, {"label": "Guidance", "count": 2}, {"label": "Capital return", "count": 1}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "59/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "78/100 classification confidence."}, {"label": "Company focus", "value": "47", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-0.9% over one week, +2.9% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Brainsway (NASDAQ:BWAY) Upgraded to Strong-Buy at Zacks Research"}], "updated_at": "2026-07-16T00:50:09.416664+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}